Clinical trial
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder…
NCT00253747 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00253747 |
|---|---|
| Title | Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
| Official title | A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers With ADHD |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD, Smoking |
| Intervention type | Drug |
| Interventions | Osmotic-Release Methylphenidate, Placebo |
| Enrollment | 255 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 15, 2005 |
| Last update posted | Sep 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: